Adragos Pharma is pleased to announce its participation in Bio-Europe 2025, taking place in Vienna, Austria, from November 3 to 5. As a global Contract Development and Manufacturing Organization (CDMO), we look forward to connecting with industry leaders, partners, and innovators to discuss the future of pharmaceutical development, manufacturing, and commercialization.
Our Commitment to Pharmaceutical Innovation
Bio-Europe 2025 serves as a leading platform for partnering, business development, and networking in the biopharmaceutical and life sciences industries. As a trusted CDMO, Adragos Pharma remains dedicated to delivering:
✔ Comprehensive CDMO solutions for pharmaceutical development and manufacturing
✔ Innovative approaches to supply chain and operational excellence
✔ Collaborative opportunities to accelerate market entry and expansion
✔ A strong commitment to quality, sustainability, and regulatory compliance
Meet our Team
Marie-Sophie Quittet
Head of Strategic Projects, Jura
Marie-Sophie holds both a Doctor of Pharmacy (PharmD) and a Doctor of Philosophy (PhD), showcasing her expertise in the pharmaceutical industry. As Head of Strategic Projects, she has over a decade of experience, spearheading clinical production projects in Europe and the US.
Meet our Team
Sofiane Borsla
Business Development Manager
Connect with Us in Vienna
Our team will be attending Bio-Europe 2025, and we welcome the opportunity to engage in discussions on potential collaborations, market insights, and strategic partnerships. If you are attending, we invite you to connect with us during the event.
📅 November 3–5, 2025
📍 Vienna, Austria
We look forward to productive discussions and new opportunities to drive innovation in pharmaceutical manufacturing and development.
